You are not logged in. enhanced features available with FREE registration!

Alternative MedicineBiotechnologyC. R. BardCardiologyClinical TrialsFDAFinanceHealth
background image

Bard Declares Quarterly Dividend

Posted: December 9, 2015 10:55 pm (UTC)

Bard Declares Quarterly Dividend


The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 24 cents per share on Bard’s common stock. The current indicated annual dividend rate is 96 cents per share. The dividend is payable on February 5, 2016 to shareholders of record at the close of business on January 25, 2016.

C. R. Bard, Inc. (, headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current expectations, the accuracy of which is necessarily subject to risks and uncertainties. These statements are not historical in nature and use words such as “anticipate”, “estimate”, “expect”, “project”, “intend”, “forecast”, “plan”, “believe”, and other words of similar meaning in connection with any discussion of future operating or financial performance. Many factors may cause actual results to differ materially from anticipated results including product developments, sales efforts, income tax matters, the outcomes of contingencies such as legal proceedings, and other economic, business, competitive and regulatory factors. The company undertakes no obligation to update its forward-looking statements. Please refer to the Cautionary Statement Regarding Forward-Looking Information in our September 30, 2015 Form 10-Q for more detailed information about these and other factors that may cause actual results to differ materially from those expressed or implied.

Tags: , , , , , , , , , , , , , , , , , , ,